Literature DB >> 8838257

Psychosocial consequences of DNA analysis for MEN type 2.

F J Grosfeld1, C J Lips, H F Ten Kroode, F A Beemer, H G Van Spijker, G J Brouwers-Smalbraak.   

Abstract

Multiple endocrine neoplasia type 2 (MEN-2) is characterized by medullary thyroid carcinoma in combination with pheochromocytomas and, sometimes, parathyroid adenomas. Since 1993, the psychosocial implications of DNA analysis for MEN-2 have been studied in the Netherlands. This article summarizes the first results of that study. Individuals who applied for DNA analysis cited the need to reduce uncertainty as the major reason for wanting the test. An unfavorable test outcome resulted in anxiety and depression but also relief. Immediate preventive treatment was preferred to continued periodic screening. Carriers were preoccupied with disease-related complaints, and identified with other carriers and MEN-2 patients. A favorable test led, in most applicants and partners, to both relief and worry. Some noncarriers felt guilty and isolated from their families. One year after counseling, participants reported fewer psychosomatic complaints.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838257

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  5 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

3.  Healthcare use after screening for lung cancer.

Authors:  Margaret M Byrne; Tulay Koru-Sengul; Wei Zhao; Joel L Weissfeld; Mark S Roberts
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 4.  Familial neuroendocrine tumor syndromes: from genetics to clinical practice.

Authors:  Akihiro Sakurai; Miyuki Katai; Kiyoshi Hashizume; Yoshimitsu Fukushima
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 5.  5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.

Authors:  Shu-Yuan Li; Yi-Qiang Ding; You-Liang Si; Mu-Jin Ye; Chen-Ming Xu; Xiao-Ping Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.